Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Growth modulation index (GMI) of larotrectinib versus prior systemic treatments for TRK fusion cancer patients
    Meeting Abstract

    Italiano, A.; Hong, D. S.; Briggs, A.; Garcia-Foncillas, J.; Lassen, U. N.; Vassal, G.; Kummar, S.; van Tilburg, C. M.; Keating, K.; Reeves, J. A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in NTRK fusion-positive NSCLC: Updated integrated analysis of STARTRK-2, STARTRK-1 and ALKA-372-001
    Meeting Abstract

    Drilon, A.; Paz-Ares, L.; Doebele, R. C.; Farago, A. F.; Liu, S. V.; Chawla, S. P.; Tosi, D.; Blakely, C. M.; Krauss, J. C.; Bazhenova, L.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Tepotinib exposure-response analyses of safety and efficacy in patients with solid tumours
    Meeting Abstract

    Paik, P. K.; Xiong, W.; Hietala, S. F.; Nyberg, J.; Papasouliotis, O.; Anziano, R.; Berghoff, K.; Johne, A.; Girard, P.; Strotmann, R.
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Patient-reported outcomes (PROs) from patients (Pts) with NTRK fusion-positive (NTRK-fp) solid tumours receiving entrectinib in the global phase II STARTRK-2 study
    Meeting Abstract

    Conley, A. P.; Demetri, G. D.; Doebele, R. C.; Drilon, A.; Paz-Ares, L.; Cassier, P.; Siena, S.; Ahn, M. J.; Buchschacher, G. L. Jr; Seto, T.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Entrectinib in patients with ROS1 fusion-positive non-small cell lung cancer (NSCLC) or NTRK fusion-positive solid tumours: Analysis of response by line of therapy
    Meeting Abstract

    Liu, S. V.; De Braud, F.; Drilon, A.; Doebele, R. C.; Patel, M. R.; Cho, B. C.; Ahn, M. J.; Chiu, C. H.; Farago, A. F.; Goto, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Intracranial efficacy of entrectinib in patients with NTRK fusion-positive solid tumours and baseline CNS metastases
    Meeting Abstract

    John, T.; Chiu, C. H.; Cho, B. C.; Fakih, M.; Farago, A. F.; Demetri, G. D.; Goto, K.; Doebele, R. C.; Siena, S.; Drilon, A.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Clinical implications of drug-induced liver injury in early-phase oncology clinical trials
    Journal Article

    Mondaca, S. P.; Liu, D.; Flynn, J. R.; Badson, S.; Hamaway, S.; Gounder, M. M.; Khalil, D. N.; Drilon, A. E.; Li, B. T.; Jhaveri, K. L.; more...
    Cancer (2020)

    Fulltext@MSK | Save
  • The METeoric rise of MET in lung cancer
    Review

    Friedlaender, A.; Drilon, A.; Banna, G. L.; Peters, S.; Addeo, A.
    Cancer (2020)

    Fulltext@MSK | Save
  • The new era in lung cancer care
    Miscellaneous

    Kris, M. G.
    Oncology (Norwalk) (2020)

    Fulltext@MSK | Save
  • KRAS(G12C) inhibition with sotorasib in advanced solid tumors
    Journal Article

    Hong, D. S.; Fakih, M. G.; Strickler, J. H.; Desai, J.; Durm, G. A.; Shapiro, G. I.; Falchook, G. S.; Price, T. J.; Sacher, A.; Denlinger, C. S.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save